Pinchman; Joseph Robert
Patent Applications and Registrations
Patent applications and USPTO patent grants for Pinchman; Joseph Robert.The latest application filed is for "nanoparticle formulation of bcl-2 inhibitor".
- Pinchman; Joseph Robert - San Diego CA
| Patent | Date |
|---|---|
| Nanoparticle Formulation Of Bcl-2 Inhibitor App 20220273666 - Pinchman; Joseph Robert ; et al. | 2022-09-01 |
| Bcl-2 Protein Inhibitors App 20220265834 - Pinchman; Joseph Robert ; et al. | 2022-08-25 |
| Benzamide Compounds App 20220226314 - Pinchman; Joseph Robert ; et al. | 2022-07-21 |
| Benzamide compounds Grant 11,344,546 - Pinchman , et al. May 31, 2 | 2022-05-31 |
| Continuous flow processes for making bicyclic compounds Grant 11,339,103 - Pinchman , et al. May 24, 2 | 2022-05-24 |
| Benzamide compounds Grant 11,318,134 - Pinchman , et al. May 3, 2 | 2022-05-03 |
| Analgesic compounds Grant 11,242,327 - Hopkins , et al. February 8, 2 | 2022-02-08 |
| Egfr Inhibitor Compounds App 20210395230 - Bunker; Kevin Duane ; et al. | 2021-12-23 |
| Estrogen Receptor Modulators App 20210330651 - Huang; Peter Qinhua ; et al. | 2021-10-28 |
| EGFR inhibitor compounds Grant 11,098,030 - Bunker , et al. August 24, 2 | 2021-08-24 |
| Estrogen receptor modulators Grant 11,065,234 - Huang , et al. July 20, 2 | 2021-07-20 |
| Estrogen receptor modulators Grant 11,065,233 - Huang , et al. July 20, 2 | 2021-07-20 |
| Bicyclic compounds Grant 10,975,035 - Bunker , et al. April 13, 2 | 2021-04-13 |
| Estrogen receptor modulators Grant 10,959,989 - Huang , et al. March 30, 2 | 2021-03-30 |
| Continuous Flow Processes For Making Bicyclic Compounds App 20210061730 - Pinchman; Joseph Robert ; et al. | 2021-03-04 |
| Benzamide Compounds App 20210009543 - Pinchman; Joseph Robert ; et al. | 2021-01-14 |
| Benzamide Compounds App 20200339605 - Pinchman; Joseph Robert ; et al. | 2020-10-29 |
| Benzamide Compounds App 20200338071 - Pinchman; Joseph Robert ; et al. | 2020-10-29 |
| Methods for cross coupling Grant 10,793,504 - Pinchman , et al. October 6, 2 | 2020-10-06 |
| Analgesic Compounds App 20200270221 - Hopkins; Chad Daniel ; et al. | 2020-08-27 |
| Spirocyclic Compounds App 20200268714 - Huang; Peter Qinhua ; et al. | 2020-08-27 |
| Estrogen Receptor Modulators App 20200261428 - Huang; Peter Qinhua ; et al. | 2020-08-20 |
| Estrogen Receptor Modulators App 20200261430 - Huang; Peter Qinhua ; et al. | 2020-08-20 |
| Estrogen Receptor Modulators App 20200261429 - Huang; Peter Qinhua ; et al. | 2020-08-20 |
| Egfr Inhibitor Compounds App 20200181120 - Bunker; Kevin Duane ; et al. | 2020-06-11 |
| Analgesic compounds Grant 10,653,681 - Bunker , et al. | 2020-05-19 |
| Spirocyclic compounds Grant 10,525,036 - Huang , et al. J | 2020-01-07 |
| EGFR inhibitor compounds Grant 10,513,509 - Bunker , et al. Dec | 2019-12-24 |
| Spirocyclic compounds Grant 10,493,060 - Huang , et al. De | 2019-12-03 |
| Bicyclic Compounds App 20190233377 - Bunker; Kevin Duane ; et al. | 2019-08-01 |
| Methods For Cross Coupling App 20190202769 - Pinchman; Joseph Robert ; et al. | 2019-07-04 |
| Spirocyclic Compounds App 20190201380 - Huang; Peter Qinhua ; et al. | 2019-07-04 |
| Bicyclic compounds Grant 10,308,609 - Bunker , et al. | 2019-06-04 |
| Estrogen Receptor Modulators App 20190142811 - Huang; Peter Qinhua ; et al. | 2019-05-16 |
| Analgesic Compounds App 20190111031 - Bunker; Kevin Duane ; et al. | 2019-04-18 |
| Analgesic Compounds App 20190099404 - Bunker; Kevin Duane ; et al. | 2019-04-04 |
| Analgesic Compounds App 20190083460 - Bunker; Kevin Duane ; et al. | 2019-03-21 |
| Analgesic Compounds App 20190060257 - Bunker; Kevin Duane ; et al. | 2019-02-28 |
| Spirocyclic Compounds App 20180207132 - Huang; Peter Qinhua ; et al. | 2018-07-26 |
| Bicyclic Compounds App 20180201614 - Bunker; Kevin Duane ; et al. | 2018-07-19 |
| Egfr Inhibitor Compounds App 20170342055 - Bunker; Kevin Duane ; et al. | 2017-11-30 |
| Bicyclic Compounds App 20160075654 - Bunker; Kevin Duane ; et al. | 2016-03-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 